Barnett-Tapia, C, Vicente, EC, Pascuzzi, RM, Utsugisawa, K, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study. JOURNAL OF NEUROLOGY. 2025; 272(12)DOI:10.1007/s00415-025-13480-8. PMID:41205003. IF:4.600(Q1/2D).

Pasquali, S, Collini, P, Romagosa, C, Coindre, JM, Pizzamiglio, S, Verderio, P, Duroni, V, Barisella, M, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Lugowska, I, Fontana, V, Bianchi, G, Palassini, E, Renne, SL, Casali, PG, Miceli, R, Sbaraglia, M, Gambarotti, M, Bagué, S, Dei Tos, AP, Stacchiotti, S, Gronchi, A. Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2025; 8(11)DOI:10.1001/jamanetworkopen.2025.40177. PMID:41196599. IF:9.700(Q1/1D).

Lazarus, JV, Agirre-Garrido, L, Miralles-Sanchez, JE, Manolas, MI, Tacke, F, Villela-Nogueira, CA, Al-Omar, HA, Alqahtani, SA, Alzubaidi, LMY, Bansal, M, Cusi, K, Isaacs, SD, Mauricio, D, Miyake, T, Moreira, RO, Nakazawa, S, Pannain, S, Pericàs, JM, Roden, M, Takahashi, H, Brachowicz, N. Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries. LIVER INTERNATIONAL. 2025; 45(12)DOI:10.1111/liv.70390. PMID:41194401. IF:5.200(Q1/2D).

Zafra-Agea, JA, Pérez, TD, Lima-Serrano, M, Vargas-Martinez, AM, Soler-Pardo, E, Torralbas-Ortega, J, Cillero, IH. Availability, perceived need and satisfaction for school nurses in Spain: a cross-sectional study involving the school community. BMC NURSING. 2025; 24(1)DOI:10.1186/s12912-025-03970-5. PMID:41188937. IF:3.900(Q1/1D).